SOCRATES-PRESERVED
Phase IIb safety and efficacy study of four dose regimens of BAY 1021189 in patients with HFpEF suffering from worsening HF (SOCRATES-PRESERVED)
- Stadium
- klaar
- Middel
- BAY-1021189
- Populatie
- Hartfalen
- Fase
- IIb
- First Patient In
- 15 november 2013
- Last Patient In
- 1 maart 2015
- Last Patient Last Visit
- -
Contact Bestuur
